{"entity":{"id":"1955","kind":"year","name":"1955 in oncology","aka":["1955"],"tldr":"Everything OnCo dates to 1955: 3 entries, 1 approval, 1 company founded and 1 landmark. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.","summary":"3 dated entries in OnCo fall in 1955: 1 approval, 1 company founded and 1 landmark.\n\nOf those, 3 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.\n\nEverything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.","asOf":"2026-09-25","links":[],"tags":[],"related":["1954","1956"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Generated from every dated field in the corpus, not written by hand. The groups and the fields behind them are listed in src/lib/year-groups.ts; the reader is src/lib/years.ts."],"year":1955,"events":[{"group":"approval","date":"1955","precision":"year","title":"Prednisone approved in US","note":"Palliative management of leukaemias and lymphomas; hypercalcaemia of malignancy; inflammatory conditions","from":"prednisone","refs":[]},{"group":"company","date":"1955","precision":"year","title":"Zeria Pharmaceutical founded","note":"Tokyo","from":"zeria","refs":[]},{"group":"history","date":"1955","precision":"year","title":"Zollinger and Ellison describe the gastrinoma syndrome","note":"Pancreatic neuroendocrine tumours","from":"pancreatic-net","refs":[]}]},"route":"/years/1955/","neighbours":{"year":[{"id":"1954","kind":"year","name":"1954 in oncology","route":"/years/1954/"},{"id":"1956","kind":"year","name":"1956 in oncology","route":"/years/1956/"}]}}